PPT-AIM 2030 Access to Innovative Medicines

Draft concept for a new World Bankled multistakeholder initiative August 2014 Andreas Seiter What is AIM 2030 An initiative to maximize access to innovative medicines for priority diseases in low and middle income countries LMICs. Access to Innovative Medicines. Draft concept for a new World Bank-led multi-stakeholder initiative . August 2014, Andreas . Seiter. What is AIM 2030?. An initiative to maximize access to innovative medicines for priority diseases in low- and middle income countries (LMICs). for asthma. WHO . Technical. Briefing . Seminar. on Essential . Medicines. & Health . Products. , Nov. 2013. Christophe Perrin, . Pharmacist. , MPH – IUATLD (The Union). Asthma. . - Global . Cochin University of Science & Technology . Sakthivel. . Selvaraj. Public Health Foundation of India . New . Delhi . (shakti@phfi.org). Access to Medicines in India . Key Barriers to . Access to Medicines . Stops AIDS National Gathering . 1st November 2014. Aliénor Devali. ère. Health. Action International (HAI) Europe. This document arises from HAI Europe’s Operating Grant 2014, which has received funding from the . Welcome. Thank you for joining us for our 1. st. AIM Opioid Webinar. Housekeeping:. Session is being recorded. Session will be posted under the opioid section of the AIM website: . https://safehealthcareforeverywoman.org/national-collaborative-on-maternal-oud/. Gilles . Forte. Coordinator, Policy, Access and Use Team. Essential . Medicines . and . Health Products. . WHO . mandate . within the . International . Drug Control Conventions. 1961 . Single Convention on Narcotic Drugs (Article 3). WHO EMP and NVI Departments. Access to NCD essential medicines . on the global agenda. Access to chronic disease medicines is required for the fulfilment of MDG8. Governments, in collaboration with the private sector, should give greater priority to treating chronic diseases and improving the accessibility of medicines to treat them (MDG Report 2009). will have a certificate or degree.. 60x30TX Builds on Past Achievements . Texas Successes Since 2000. 2.6 million undergraduate credentials awarded. 60.5% six-year public university graduation rate, up from 49.6%. Dr Cécile . Macé. . WHO EMP , Mr Arne-Petter . Sanne. WHO MND, . Mr . Ajuebor. Onyema WHO MND. NCD Programme Managers Seminar. 4 June 2014. Access to NCD essential medicines . on the global agenda. July 24, 2018. Kitu Systems. 1. Gordon Lum. Kitu Systems. Agenda. Brief IEEE 2030.5 Overview. IEEE 2030.5 TLS Cipher Suite. IEEE 2030.5 Public Key Infrastructure (PKI). July 24, 2018. Kitu Systems. 2. how . the pandemic has influenced the disease burden. Bengt . Jönsson. Professor emeritus, Stockholm School of Economics. Wednesday, 1 July 2020 – 16.30-19.00 CET (online event. ). Launch of the European Parliament  . . Associate Professor Nicole Pratt . Quality use of medicines and pharmacy research centre. University of South Australia. overview. Biologic medicines, or immune based therapies, are a rapidly evolving group of pharmaceutical products whose active component is biologically derived rather than chemically synthesised. . and policy makers for the 2030 . Agenda – . Sweden . Cristina Mattsson Lundberg. Ministry of the Environment. Viggo Barmen. Ministry of Foreign Affairs . Gabriel Wikström. National Coordinator of the 2030 Agenda. www.risk-society.com. . Ms. . Magda Stepanyan, . Founder & CEO at Risk Society. Monitoring progress under the Hyogo Framework for . Action (HFA . Monitor) : . 2005-2015. 22 Core indicators . in .